Jefferies Financial Group Reiterates Buy Rating for Johnson Matthey (LON:JMAT)

Jefferies Financial Group reissued their buy rating on shares of Johnson Matthey (LON:JMAT) in a report published on Tuesday, Marketbeat.com reports. The firm currently has a GBX 1,800 ($22.50) target price on the stock.

Separately, Berenberg Bank reduced their price target on Johnson Matthey from GBX 1,650 ($20.62) to GBX 1,500 ($18.75) and set a “hold” rating on the stock in a research report on Thursday, November 28th.

Johnson Matthey Trading Down 1.2 %

Shares of JMAT opened at GBX 1,335 ($16.69) on Tuesday. Johnson Matthey has a 12 month low of GBX 1,318 ($16.47) and a 12 month high of GBX 1,917.07 ($23.96). The stock’s 50-day moving average is GBX 1,471.17 and its two-hundred day moving average is GBX 1,569.87. The company has a debt-to-equity ratio of 63.15, a current ratio of 1.45 and a quick ratio of 0.76. The stock has a market cap of £2.33 billion, a PE ratio of 2,301.72, a P/E/G ratio of 49,242.50 and a beta of 0.95.

Johnson Matthey Cuts Dividend

The firm also recently announced a dividend, which will be paid on Tuesday, February 4th. Stockholders of record on Thursday, December 5th will be paid a dividend of GBX 22 ($0.27) per share. The ex-dividend date is Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey’s dividend payout ratio is presently 13,275.86%.

Insider Transactions at Johnson Matthey

In related news, insider Stephen Oxley bought 24 shares of the business’s stock in a transaction dated Wednesday, November 20th. The shares were acquired at an average price of GBX 1,504 ($18.80) per share, for a total transaction of £360.96 ($451.14). Also, insider Liam Condon purchased 27 shares of Johnson Matthey stock in a transaction dated Wednesday, October 16th. The shares were bought at an average cost of GBX 1,505 ($18.81) per share, for a total transaction of £406.35 ($507.87). Over the last ninety days, insiders have acquired 7,458 shares of company stock valued at $10,024,332. 0.61% of the stock is currently owned by insiders.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.